PharmaLogic Buys Lantheus CDMO Business and Springfield Plant
PharmaLogic will acquire Lantheus' CDMO business and Springfield, NJ plant, gaining U.S. radiopharmaceutical capacity plus a long-term deal to make lutetium Lu 177 dotatate for Lantheus. Terms undisclosed.
